Prostate Cancer

Jazz tunes rather than the searing blues-based rock songs Wells played punctuated the moving eulogies delivered by his brother-in-law Greg Young, daughter Katrina Kennedy and former Buffalo bandmate and lifelong friend Dave Tice.

Tice, a stalwart of Sydney's blues scene, spoke of Wells' enormous generosity and sharp, dry wit.

"When I turned 50, a taxi driver appeared at my door and handed me a guitar case," Tice recalled yesterday.

"There was a shiny new red guitar.

When I rang to thank him, he said, 'No worries, mate.

It's about time you sharpened up your image.' " Have your say Print this story Also in Confidential Jana's race down the aisle Hutchence goes to Hollywood Murmurs...

Jennifer Hawkins - her life in pictures Prayers for the dead Father's plea for tough police action Terror attack tomorrow, warn Indonesians Rents soar 'Not ashamed' Cig breaks banned Naomi's phone fit Family's joy at release of journalist Bin Laden: I won't be taken alive Dogs star axed Stormy passage Kasper fights for his future Brit's law suit Hero Hugo Hinch linked to sex scandal Jana's race down the aisle Rockers gather to farewell a friend Hutchence goe...

Usually patients undergo a prostate biopsy when they are found to have an elevated serum PSA.

About 10% of patients who undergo a prostate biopsy will be found to have high grade PIN.

Men with high grade PIN have an approximately 50 percent chance of progressing to In the United States, 1.1 million men have been diagnosed with high grade PIN, and it has been estimated that there are 14 million men who may unknowingly harbor the condition.

There are no medical treatments for high grade PIN.The Poster is scheduled to be presented Wednesday, April 5, 2006, 8 a.m.

- 12 p.m.

- Identification of ABCA5 as a tissue and urine diagnostic market for Prostatic Intraepithelial Neoplasia (PIN).

Abstract Number: 5163; Poster Section: 25; Board 7.

About GTxGTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics for cancer and serious conditions related to men's health.

GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones.

GTx, headquartered in Memphis, Tenn., currently has four clinical programs.

GTx is developing ACAPODENE® (toremifene citrate), a selective estroge...